Truist Financial’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Hold
96,250
﹤0.01% 2413
2026
Q1
$380K Hold
96,250
﹤0.01% 2249
2025
Q4
$652K Hold
96,250
﹤0.01% 1889
2025
Q3
$672K Hold
96,250
﹤0.01% 1856
2025
Q2
$588K Buy
96,250
+43,000
+81% +$286K ﹤0.01% 1884
2025
Q1
$405K Hold
53,250
﹤0.01% 1984
2024
Q4
$512K Hold
53,250
﹤0.01% 1861
2024
Q3
$315K Hold
53,250
﹤0.01% 2102
2024
Q2
$369K Buy
53,250
+35,000
+192% +$246K ﹤0.01% 2169
2024
Q1
$141K Hold
18,250
﹤0.01% 2532
2023
Q4
$160K Hold
18,250
﹤0.01% 2532
2023
Q3
$133K Hold
18,250
﹤0.01% 2493
2023
Q2
$121K Hold
18,250
﹤0.01% 2498
2023
Q1
$62.2K Sell
18,250
-750
-4% -$2.9K ﹤0.01% 2529
2022
Q4
$52.8K Hold
19,000
﹤0.01% 2516
2022
Q3
$55K Hold
19,000
﹤0.01% 2463
2022
Q2
$66K Sell
19,000
-1,280
-6% -$5.01K ﹤0.01% 2566
2022
Q1
$96K Hold
20,280
﹤0.01% 2614
2021
Q4
$122K Hold
20,280
﹤0.01% 2664
2021
Q3
$123K Sell
20,280
-250
-1% -$2.82K ﹤0.01% 2634
2021
Q2
$257K Buy
20,530
+1,280
+7% +$13.9K ﹤0.01% 2464
2021
Q1
$198K Hold
19,250
﹤0.01% 2499
2020
Q4
$175K Buy
+19,250
New +$139K ﹤0.01% 2406

Other funds holding MDXG

Truist Financial's MDXG Position: Q2 2026 in Review

Truist Financial held its MiMedx Group (MDXG) position steady in Q2 2026 at 96,250 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Truist Financial first reported a position in MDXG in Q4 2020 and has held it in 23 quarters since. The position peaked at $672K in Q3 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Truist Financial held 96,250 shares of MiMedx Group worth $371K as of Q2 2026.
  • Truist Financial left its MiMedx Group share count unchanged in Q2 2026.
  • MiMedx Group made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2413 holding.
  • Truist Financial first reported a position in MiMedx Group in Q4 2020 and has held it in 23 quarters since.
  • Truist Financial's MiMedx Group position peaked at $672K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.